@article{boissel:hal-03789523,
TITLE = {Frontline Consolidation with Blinatumomab for High-Risk Philadelphia-Negative Acute Lymphoblastic Adult Patients. Early Results from the Graall-2014-QUEST Phase 2},
AUTHOR = {Boissel, Nicolas and Huguet, Francoise and Graux, Carlos and Hicheri, Yosr and Chevallier, Patrice and Kim, Rathana and Balsat, Marie and Leguay, Thibaut and Hunault, Mathilde and Maury, S{\'e}bastien and Thiebaut-Bertrand, Anne and Escoffre-Barbe, Martine and Cluzeau, Thomas and Villate, Alban and Pasquier, Florence and Farnault, Laure and van Obbergh, Florence and Rousselot, Philippe and Chalandon, Yves and Delabesse, Eric and Pastoret, Cedric and Clappier, Emmanuelle and Lheritier, Veronique and Dombret, Herve},
URL = {https://hal.science/hal-03789523},
JOURNAL = {Blood},
PUBLISHER = {American Society of Hematology},
SERIES = {614.Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies},
VOLUME = {138},
NUMBER = {Supplement 1},
PAGES = {1232-1232},
YEAR = {2021},
MONTH = Nov, DOI = {10.1182/blood-2021-146163},
HAL_ID = {hal-03789523},
HAL_VERSION = {v1},
}